Used in Suzuki-Miyaura cross-coupling reactions as a boronic acid reagent for constructing biaryl compounds in pharmaceutical synthesis. The pyridylcarbamoyl group enhances solubility and can act as a directing group or coordination site in metal-catalyzed reactions. Commonly applied in the development of kinase inhibitors and other bioactive molecules where aryl-aryl linkages are required. Its structure allows for further functionalization through amide bond formation, enabling use in combinatorial chemistry and drug discovery. Stable under standard conditions and compatible with a variety of coupling partners, making it valuable in medicinal chemistry research.